epigenetic platform

Mnemo Therapeutics, epigenetic platform, Series A funding, biotechnology
France-based Mnemo Therapeutics raises €75M Series A round
By Sara Mageit | 07:55 am | June 16, 2021
The healthtech company aims to accelerate its next generation integrated CAR-T and epigenetic targeting platform.